Covid-19 roundup: Mod­er­na re­claims vac­cine mar­ket­ing rights in Japan; New IP waiv­er draft

Mod­er­na and Take­da ap­pear to be chang­ing their arrange­ment around the Spike­vax vac­cine dis­tri­b­u­tion in Japan.

The two phar­ma com­pa­nies will trans­fer the mar­ket­ing au­tho­riza­tion …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER